Has Emanuel Nogueira, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,229 in general payments to Emanuel Nogueira, MD across 17 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Emanuel Nogueira, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Emanuel Nogueira, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Emanuel Nogueira, MD

Surgery · Quakertown, PANPI 1659563807

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Covidien LP accounts for 61.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $1,998 and has fallen 76.4% since, to $471 in 2025.

$3,229in general payments, 2019–2025

Across 17 payments — averaging $189.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Covidien LP$2K
Davol Inc.$881
Johnson & Johnson$203
Boston Scientific$129
TELA Bio, Inc.$19

What the payments were for

Consulting fees$1,91959%
Travel & lodging$873%
Food & beverage$1,22338%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Covidien LP	5	$1,997
Davol Inc.	9	$881
Johnson & Johnson	1	$203
Boston Scientific	1	$129
TELA Bio, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,229 in reported general payments places this provider in the 65th percentile of 1,424 surgery providers in Pennsylvania.

See all surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$122,531

Medicare patients

255

Services billed

589

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	17	$164

Paid to pharmacies, not to this prescriber.

Other surgery in Quakertown

Andy KiserPittsburgh$1M
Glenn SteeleDanville$698K
Maher El ChaarAllentown$667K
George EidPittsburgh$619K
Paul CesanekAllentown$469K
Clark GerhartPlains$317K
Irina YermilovPlymouth Meeting$315K
Eric PauliHershey$202K
Ariel AballayPittsburgh$198K
Ann RogersHershey$198K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →